Are Investors Undervaluing STERIS Plc (NYSE:STE) By 42%?
Reasons to Retain STE Stock in Your Portfolio Now
Is Now The Time To Look At Buying STERIS Plc (NYSE:STE)?
Piper Sandler Maintains Steris PLC(STE.US) With Buy Rating, Maintains Target Price $260
What You Can Learn From STERIS Plc's (NYSE:STE) P/E
New Alliances to Support STERIS Stock Despite Macro Issues
Steris PLC To Go Ex-Dividend On November 19th, 2024 With 0.57 USD Dividend Per Share
November 17th (Eastern Time) - $Steris PLC(STE.US)$ is trading ex-dividend on November 19th, 2024.Shareholders of record on November 19th, 2024 will receive 0.57 USD dividend per share on December 19
These 4 Measures Indicate That STERIS (NYSE:STE) Is Using Debt Reasonably Well
Express News | Steris PLC : Stephens Cuts Target Price to $250 From $260
Assessing MedTech Impact From Potential China Tariffs
Morgan Stanley Maintains Steris PLC(STE.US) With Hold Rating, Raises Target Price to $230
Wolfe Research Adjusts STERIS' Price Target to $265 From $250
Decoding Steris PLC (STE): A Strategic SWOT Insight
Q2 2025 STERIS Plc Earnings Call
Needham Maintains Steris PLC(STE.US) With Hold Rating
STERIS Plc (STE) Q2 2025 Earnings Call Transcript Summary
STERIS Plc (STE) Q2 2025 Earnings Call Transcript
STERIS Down Nearly 6%, on Pace for Largest Percent Decrease Since February 2023 -- Data Talk
Steris Analyst Ratings
Express News | Steris Shares Down 5.2% After Q2 Results